Global Next-Generation Sequencing (NGS) Services Market Research Report 2025

Publication ID:

PB504253928

Publication Date:

April 9, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Next-Generation Sequencing (NGS) Services was valued at US$ 4904 million in the year 2024 and is projected to reach a revised size of US$ 13190 million by 2031, growing at a CAGR of 15.4% during the forecast period.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Sequencing (NGS) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Sequencing (NGS) Services.
The Next-Generation Sequencing (NGS) Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next-Generation Sequencing (NGS) Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Sequencing (NGS) Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Sequencing (NGS) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Next-Generation Sequencing (NGS) Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Sequencing (NGS) Services Market Perspective (2020-2031)
2.2 Global Next-Generation Sequencing (NGS) Services Growth Trends by Region
2.2.1 Global Next-Generation Sequencing (NGS) Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Next-Generation Sequencing (NGS) Services Historic Market Size by Region (2020-2025)
2.2.3 Next-Generation Sequencing (NGS) Services Forecasted Market Size by Region (2026-2031)
2.3 Next-Generation Sequencing (NGS) Services Market Dynamics
2.3.1 Next-Generation Sequencing (NGS) Services Industry Trends
2.3.2 Next-Generation Sequencing (NGS) Services Market Drivers
2.3.3 Next-Generation Sequencing (NGS) Services Market Challenges
2.3.4 Next-Generation Sequencing (NGS) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue
3.1.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue (2020-2025)
3.1.2 Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Players (2020-2025)
3.2 Global Next-Generation Sequencing (NGS) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Next-Generation Sequencing (NGS) Services Revenue
3.4 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio
3.4.1 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Sequencing (NGS) Services Revenue in 2024
3.5 Global Key Players of Next-Generation Sequencing (NGS) Services Head office and Area Served
3.6 Global Key Players of Next-Generation Sequencing (NGS) Services, Product and Application
3.7 Global Key Players of Next-Generation Sequencing (NGS) Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Sequencing (NGS) Services Breakdown Data by Type
4.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Type (2020-2025)
4.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Type (2026-2031)
5 Next-Generation Sequencing (NGS) Services Breakdown Data by Application
5.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Application (2020-2025)
5.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Next-Generation Sequencing (NGS) Services Market Size (2020-2031)
6.2 North America Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2020-2025)
6.4 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Sequencing (NGS) Services Market Size (2020-2031)
7.2 Europe Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2020-2025)
7.4 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size (2020-2031)
8.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-Generation Sequencing (NGS) Services Market Size (2020-2031)
9.2 Latin America Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (2020-2025)
9.4 Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size (2020-2031)
10.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Introduction
11.1.4 Eurofins Scientific Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.1.5 Eurofins Scientific Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Next-Generation Sequencing (NGS) Services Introduction
11.2.4 Natera Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.2.5 Natera Recent Development
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI Next-Generation Sequencing (NGS) Services Introduction
11.3.4 BGI Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.3.5 BGI Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Next-Generation Sequencing (NGS) Services Introduction
11.4.4 Illumina Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Next-Generation Sequencing (NGS) Services Introduction
11.5.4 Roche Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Next-Generation Sequencing (NGS) Services Introduction
11.6.4 LabCorp Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Introduction
11.7.4 Berry Genomics Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.7.5 Berry Genomics Recent Development
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Details
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Introduction
11.8.4 Brooks Life Sciences Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.8.5 Brooks Life Sciences Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Next-Generation Sequencing (NGS) Services Introduction
11.9.4 Macrogen Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.9.5 Macrogen Recent Development
11.10 Personalis
11.10.1 Personalis Company Details
11.10.2 Personalis Business Overview
11.10.3 Personalis Next-Generation Sequencing (NGS) Services Introduction
11.10.4 Personalis Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.10.5 Personalis Recent Development
11.11 Novogene
11.11.1 Novogene Company Details
11.11.2 Novogene Business Overview
11.11.3 Novogene Next-Generation Sequencing (NGS) Services Introduction
11.11.4 Novogene Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.11.5 Novogene Recent Development
11.12 Genotypic Technology
11.12.1 Genotypic Technology Company Details
11.12.2 Genotypic Technology Business Overview
11.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Introduction
11.12.4 Genotypic Technology Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.12.5 Genotypic Technology Recent Development
11.13 Dna Link
11.13.1 Dna Link Company Details
11.13.2 Dna Link Business Overview
11.13.3 Dna Link Next-Generation Sequencing (NGS) Services Introduction
11.13.4 Dna Link Revenue in Next-Generation Sequencing (NGS) Services Business (2020-2025)
11.13.5 Dna Link Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂